United States - English - NLM (National Library of Medicine)

siddha flower essences llc - bromus ramosus flower (unii: 0w9o574le8) (bromus ramosus flower - unii:0w9o574le8), calcium fluoride (unii: o3b55k4yki) (fluoride ion - unii:q80vpu408o), centaurium erythraea flower (unii: b204p54z1f) (centaurium erythraea flower - unii:b204p54z1f), ferrosoferric phosphate (unii: 91gqh8i5f7) (ferrosoferric phosphate - unii:91gqh8i5f7), ilex aquifolium flowering top (unii: 5enr9san1w) (ilex aquifolium flowering top - unii:5enr9san1w), potassium phosphate, dibasic (unii: ci71s98n1z) (potassium cation - - bromus ramosus flower 5 [hp_x] in 29.6 ml - each dose contains equal parts of: bromus ramosus, flos (wild oat) 5x hpus........................uncertainty about ambitions calc fluor 12x hpus.......................................................indecision centaurium umbellatum, flos (centaury) 5x hpus..............weakness of will; inability to say no fer phos 12x hpus.........................................................anxiety in the heart; soft pulse; confusion of mind ilex aquifolium, flos (holly) 5x hpus..................................frequently feel offended or hurt kali phos 6x hpus.........................................................exhaustion after moderate mental effort mag phos 12x hpus.......................................................nervous palpitation, persistent depression of spirits nat mur 6x hpus............................................................heart feels constricted; flutterin

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - benzydamine hydrochloride; cetylpyridinium chloride - oromucosal spray, solution - 1.5 mg/ml+5.0 milligram(s)/millilitre - antiseptics; various - throat preparations, antiseptics - it is indicated in adults and children over 6 years of age for anti-inflammatory, analgesic and antiseptic treatment of irritations in the throat, mouth and gums, in gingivitis, pharyngitis and laryngitis and before and after tooth extractions

European Union - English - EMA (European Medicines Agency)

belpharma s.a. - tasonermin - sarcoma - immunostimulants, - beromun is indicated in adults as an adjunct to surgery for subsequent removal of the tumour so as to prevent or delay amputation, or in the palliative situation, for irresectable soft-tissue sarcoma of the limbs, used in combination with melphalan via mild hyperthermic isolated-limb perfusion (ilp).

Ireland - English - HPRA (Health Products Regulatory Authority)

orion corporation - detomidine hydrochloride - oromucosal gel - 7.6 milligram(s)/millilitre - detomidine - horses - neurological preparations

United States - English - NLM (National Library of Medicine)

alk-abello, inc. - bromus inermis pollen (unii: 766qt72bk6) (bromus inermis pollen - unii:766qt72bk6) - bromus inermis pollen 10000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w

United States - English - NLM (National Library of Medicine)

jubilant hollisterstier llc - bromus inermis pollen (unii: 766qt72bk6) (bromus inermis pollen - unii:766qt72bk6) - bromus inermis pollen 0.05 g in 1 ml - certain diagnostics carry labeling which states allergenic extract for diagnostic use only . data to support the therapeutic use of products labeled with this statement have not been established. 14 in addition to a carefully taken history, the use of glycerin-containing extracts in scratch, prick or puncture testing is an accepted method in the diagnosis of allergic conditions. 1, 2, 3 extracts of all allergens do not produce equivalent results in scratch, prick or puncture tests. the intensity of the skin reactions produced will be determined by two factors: the degree of sensitivity of the patient, and the nature of the allergenic extract applied. scratch, prick or puncture tests are not as sensitive as the intradermal test, but are safer and cause less discomfort. they may, therefore, be the method of choice when a large number of tests are needed, or when testing the pediatric patient. in some cases, where the relatively insensitive scratch, prick or puncture tests are negative or do not confirm the

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

johnson & johnson ltd - miconazole - oromucosal gel - 20mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dendron ltd - aminoacridine hydrochloride; lidocaine hydrochloride - oromucosal gel - 500microgram/1gram ; 6.6mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mcneil products ltd - miconazole - oromucosal gel - 20mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dendron ltd - aminoacridine hydrochloride; lidocaine hydrochloride - oromucosal gel - 500microgram/1gram ; 6.6mg/1gram